Revista Española de Cardiología (English Edition) Revista Española de Cardiología (English Edition)
Rev Esp Cardiol. 2010;63:810-9 - Vol. 63 Num.07 DOI: 10.1016/S1885-5857(10)70166-3

Cardiovascular Adaptation, Functional Capacity and Angiotensin-Converting Enzyme I/D Polymorphism in Elite Athletes

Araceli Boraita a, Alejandro de la Rosa b, María E. Heras a, Ana I. de la Torre a, Alicia Canda a, Manuel Rabadán a, Ángel E. Díaz a, César González a, Marta López c, Mariano Hernández c

a Servicio de Cardiología, Cineantropometría, Fisiología y Laboratorio Clínico, Centro de Medicina del Deporte, Consejo Superior de Deportes, Madrid, Spain
b Servicio de Cardiología, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain
c Laboratorio de Genética, Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, La Laguna, Santa Cruz de Tenerife, Spain

Keywords

ACE polymorphism. Sport. Cardiovascular adaptation. Body composition.

Abstract

Introduction and objectives. Angiotensin-converting enzyme (ACE) is associated with the development of cardiac hypertrophy and improved physical fitness. The objective of this study was to investigate the relationship between the ACE gene insertion/deletion (I/D) polymorphism and adaptation to sports training. Methods. The study included 299 elite Spanish athletes (193 men and 106 women) from 32 different sports disciplines, which were grouped according to their static and dynamic components. All participants underwent body composition analysis, Doppler echocardiography at rest, and ergospirometry. Their ACE genotype was determined using the polymerase chain reaction. Results. The most common genotype in both males and females was the deletion-insertion (DI) heterozygote (57.5% and 54.7%, respectively), followed by the DD homozygote (30.6% and 34.9%), and the II homozygote (11.9% and 10.4%). Differences in morphometric and functional cardiac adaptation were observed between the different sports disciplines, but there was no statistically significant relationship with the ACE I/D polymorphism. Moreover, when athletes with different genotypes were compared, the only differences observed were between the DD and DI groups in female athletes, who differed in body mass index and longitudinal right atrial dimension. Conclusions. The ACE I/D polymorphism did not appear to influence cardiovascular adaptation in response to training. However, the DI genotype was the most common, probably because the sample was biased by being made up of elite athletes.

Article

INTRODUCTION

Physiologic cardiac hypertrophy in athletes is known as "athletic heart syndrome."1 The reninangiotensin-aldosterone system (RAAS) has an influence on myocardial growth: angiotensin II stimulates synthesis of cardiac proteins, whereas bradykinins have an antiproliferative effect.2 Physical exercise activates RAAS, and overstimulation during long training periods has been related to the development of left ventricular hypertrophy. In elite athletes and those undergoing aerobic endurance training, physiologic hypertrophy is more evident.3 Nonetheless, not all athletes who perform similar aerobic training acquire the same degree of hypertrophy, and this suggests that genetic factors may have an influence on heart size.

The genes coding for RAAS components regulate the concentration of angiotensin-converting enzyme (ACE), as well as function and expression of angiotensin II.4 There seems to be a relationship between the insertion/deletion (I/D) polymorphism of a 287-bp Alu element in intron 16 of the ACE gene and the degree of activity of the enzyme in plasma and tissue. The D allele is associated with higher levels of activity and a greater probability that hypertrophy will occur with exercise; nonetheless, the role of ACE gene I/D polymorphism in the development of athlete heart syndrome remains unclear. Some authors consider that cardiac hypertrophy in response to training is independent of the I/D genotype.5,6 Others report an association, although with disparate findings: for some authors,7,8 hypertrophy in athletes who practice predominantly aerobic sports is associated with genotypes DD and DI or with the presence of the D allele, whereas others9 have found a greater frequency of the I allele.

The aim of this study was to determine the relationship between I/D polymorphism of the ACE gene and adaptation to training in elite Spanish athletes practicing various sports disciplines.

METHOD

Study Population

Among the overall population of elite athletes who came to the Center for Sports Medicine of the National Sports Council of Spain (CSD, Consejo Superior de Deportes) during the 2007 to 2008 season for a medical-sport check-up, 299 signed an informed consent form for participation in the study: 193 men (mean age, 23.8 [5.8] years) and 106 women (23.7 [5.6] years) practicing 32 sports disciplines. Subjects were grouped attending to the dynamic and static components of their activity, determined according to the sports classification of Mitchell.10 The dynamic component (endurance) is defined as class A (low), B (moderate), or C (high) when the oxygen uptake (VO2) required during competition is <40%, between 40% and 70%, or >70% of the maximal VO2 (VO2max). The static component (power) is categorized as class I (low), II (moderate), or III (high), according to whether the maximal voluntary contraction (MVC) is <20%, 20% to 50%, or >50%. The various sports categorized according to the Mitchell classification10 are shown in Table 1.

TABLE 1. Distribution of Sports According to Their Static and Dynamic Components

Genetic Study of Angiotensin-Converting Enzyme

Blood samples were drawn into EDTA-K3 tubes. A 185 µL amount of sample was placed on a Whatman FTA Card (VWR International Eurolab, S.L. ref. WHATWB120210). A circle 1-mm in diameter was then cut from the card and incubated in 200 µL of TE buffer (Tris-HCl 10 mmol and EDTA 1 mmol, pH 8) at room temperature for 2 h. DNA extraction consisted of digestion with proteinase K, protein precipitation with ammonium acetate (ACNH4) 4 mol, and posterior DNA precipitation with ethanol. Twenty 20 ng of DNA was used for PCR amplification of a fragment of intron 16 of the ACE gene, which contains the I/D polymorphism (rs 4646994). The primers used were ACE1F, 5'-CTGGAGACCACTCCCATCCTTTCT-3' and ACE1R, 5'-GATGTGGCCATCACATTCGTCAGAT-3', which generate a 234-bp product and 480-bp product for the D and I alleles, respectively.

In all samples in which only the D allele was amplified, presumably because subjects were homozygous for DD, separate amplification was performed using the primers ACE2F, 5'-TGGGACCACAGCGCCCGCCACTAC-3' and ACE2R, 5'-TCGCCAGCCCTCCCATGCCCATAA-3', to confirm the absence of allele I. This amplification yields a 336-bp fragment only when the sample contains allele I.

In addition to this second amplification and to ensure the accuracy of genotyping, 20% of the samples were reanalyzed; confirmation of the genotype obtained in the first analysis was 100%.

Anthropometric Study

The variables included in the anthropometric study were weight, height, 3 perimeters (arm, thigh, and leg), and 8 skinfolds (iliac crest, supraspinal, abdominal, subscapular, biceps, triceps, anterior thigh, and medial leg). Measurements were carried out with a Seca Delta scale, stadiometer, metric tape measure, and Holtain skinfold calipers, using the technique recommended by the International Society for the Advancement of Kinanthropometry (ISAK).11 The following parameters were calculated: body surface area (BSA), sum of skinfold results, percentage of body fat,12,13 muscle mass and percentage of muscle mass,14 body mass index (BMI), and fat-free mass index (FFMI), which was calculated by subtracting the fat mass from the total body mass and dividing the result by the square of the height in meters.

Cardiologic Study

None of the athletes studied had a history of hypertension, smoking, or kidney disease, or a family history of hypertrophic cardiomyopathy or sudden death. A cardiovascular examination, 12-lead electrocardiography at rest (General Electric MAC 5000 electrocardiograph), and echocardiography (Phillips Sonos 7500, 2-4 MHz multifrequency transducer) were performed. Two experienced observers analyzed the measurements. Heart chamber diameters and wall thickness were measured in a parasternal, long-axis view (M mode), following the recommendations of the American Society of Echocardiography.15,16 The left ventricular mass was calculated with the formula of Devereux and Reichek,17 and the left ventricular mass index was determined by dividing this value by the body surface area.

Ergospirometry

Maximal exercise testing was performed with the use of a treadmill (Jaeger LE 580 C) or cycle ergometer (Jaeger ER 900), applying incremental ramp protocols. The treadmill protocol was as follows: 2-minute warm-up (4 km/h women and 6 km/h men), initial exercise phase to 6 and 8 km/h, respectively, with an increase of 0.25 km/h every 15 s and constant slope of 1% up to minute 13, at which time increases were 0.25% every 15 s. In the cycle ergometry test, warm-up was 1 min at 25 W, with a 5 W load increase every 12 s at a pedal rate of 65 to 90 rpm.18 In the 12-lead electrocardiographic monitoring (General Electric CASE 8000) and analysis of respiratory gas exchange and pulmonary ventilation (Jaeger Oxycon Pro ergospirometer), the absolute VO2max and VO2max relative to body weight (VO2kg max), pulmonary ventilation, heart rate, oxygen pulse, and blood pressure values were obtained. The criteria used to determine the VO2max19 were the presence of a plateau in the VO2 curve or a respiratory ratio >1.1.

Statistical Study

Statistical analysis were performed with SPSS (version 12.0) for Windows. Descriptive and comparative analyses of the data obtained were carried out according to sex, sports discipline, and ACE polymorphism, using the Student t test and ANOVA. Data are expressed as the mean (SD). The Levene test was applied to confirm the homogeneity of the variables, and the Bonferroni test or Games-Howell test were used in cases of homogeneity or heterogeneity. The distribution of the various polymorphisms in the sample and their relationship with the sports disciplines were studied with the chi-square test. Differences were considered statistically significant at a P value of ≤.05.

RESULTS

Distribution of Insertion/deletion Polymorphism of Angiotensin-Converting Enzyme

The D allele was found in 60.4% of our sample and the I allele in 39.6%. Genotype distribution of ACE I/D polymorphism by categories according to the Mitchell classification10 is shown in Figure 1. The most frequent genotype in both men and women was DI (57.55 and 54.7%, respectively) and the least frequent was II (11.9% and 10.4%, respectively). The DD genotype was found in 30.6% of men and 34.9% of women. The genotype frequencies did not conform to Hardy-Weinberg equilibrium because of an excess of DI heterozygotes. There were no differences in genotype distribution between men and women.

Figure 1. Distribution of angiotensin-converting enzyme I/D polymorphism genotypes according to static and dynamic components of the sports. Mitchell classification10: A, low dynamic component; B, moderate dynamic component; C, high dynamic component; I, low static component; II, moderate static component; III, high static component.

Figure 1. Distribution of angiotensin-converting enzyme I/D polymorphism genotypes according to static and dynamic components of the sports. Mitchell classification10: A, low dynamic component; B, moderate dynamic component; C, high dynamic component; I, low static component; II, moderate static component; III, high static component.

There was no association between ACE I/D polymorphism and the sports categories of the Mitchell classification.10 The genotypes found in the various sports activities having more than 12 participants (running long and middle-distance, field hockey, fencing, field event jumping, running sprint, artistic gymnastics, karate, judo, swimming, triathlon, and boxing) were compared (Figure 2), but there were no significant differences between the groups. Of note, genotype II was not found in any of the athletes practicing karate (DD, 23.1%; DI, 76.9%), and genotype DD was the most prevalent in the group practicing artistic gymnastics (DD, 66.6%; DI and II, 16.6%) and sprinting (DD, 52.6%; DI, 36.8%; II, 10.5%). When power sports (artistic gymnastics, jumping, and sprinting) and aerobic endurance sports (middle/long distance running and triathlon) were analyzed separately, however, there was an association with ACE I/D polymorphism (c2=6.03; P<.049): genotype DD was more common in power sports (48.8%) and DI in endurance sports (58%), although the D allele predominated in both groups (65.8% in power and 61.2% in endurance).

Figure 2. Distribution of angiotensin-converting enzyme I/D polymorphism genotypes in various sports disciplines.

Figure 2. Distribution of angiotensin-converting enzyme I/D polymorphism genotypes in various sports disciplines.

Adaptation to Training and Insertion/Deletion Polymorphism

Anthropometric Study

The anthropometric characteristics of the sample grouped according to ACE gene polymorphisms are shown in Table 2. No statistically significant differences were found between the groups, with the exception of the BMI between genotype DD and genotype DI (P<.03) in women. With regard to sex, there were significant differences (P<.0001) in all the anthropometric variables, with men showing greater weight, height, muscle mass, BMI, and FFMI than women, whereas women showed a larger fat mass and percentage of body fat.

TABLE 2. Anthropometric Characteristics of Athletes According to Angiotensin Converting Enzyme I/D Polymorphism

Cardiologic and Ergospirometric Study

No differences were found between men and women for baseline heart rate (HR) (56.8 [9.7] and 58.1 [10.5] bpm) or maximum HR recorded during the exercise test (189.5 [9.5] and 188.4 [8.9] bpm). There were, however, differences in the baseline systolic pressure (117.5 [10.4] and 108.1 [10.1] mmHg) and diastolic pressure (67.1 [7.6] and 62.3 [7.1] mmHg), which were higher in men. Comparison of these variables between the different ACE I/D polymorphism genotypes in both sexes yielded no significant differences.

The echocardiographic and ergospirometric values obtained according to ACE I/D polymorphism group are shown in Tables 3 and 4. Significant differences were found for the VO2max and echocardiographic variables between men and women. There were no differences in any of the echocardiographic or ergospirometric variables in men grouped according to the static component of the Mitchell sports classification.10 In women, differences were found for interventricular septum (IVS) thickness between sports having a low or high static component (IVS, 7.4 [0.99] and 8.18 [1.08] mm, respectively) and for the BSA adjusted left ventricular mass (LVM/ BSA, 74.5 [18.3] and 84.5 [17.8] g/m2, respectively); women in group III also presented greater left ventricular hypertrophy.. Considering the dynamic component, athletes belonging to sports group C (both men and women) presented the highest values for wall thickness, end-diastolic volume, and BSA-adjusted left ventricular mass, as well as higher oxygen uptake, as compared to groups A and B.

TABLE 3. Echocardiographic Parameters in Athletes According to Angiotensin Converting Enzyme I/D Polymorphism

TABLE 4. Maximal Ergospirometric Parameters in Athletes According to Angiotensin Converting Enzyme I/D Polymorphism

Separate analysis in men and women of the relationships between the variables studied and ACE polymorphism showed no significant differences except in the longitudinal right atrial dimension between genotypes DD and DI in women (P=.005).

DISCUSSION

In this study, there was no association between ACE gene I/D polymorphism and the various sports studied, grouped by their dynamic and static components according to the Mitchell classification.10 The most frequent genotype found was the DI heterozygote, followed by the DD and II homozygotes. An association was found, however, when power sports and predominantly aerobic sports were separated, with a higher prevalence of the DD genotype in power sports and a higher prevalence of the DI genotype in aerobic sports.

The best cardiovascular adaptation in both sexes was observed in athletes practicing category C sports (oxygen uptake in competition >70% of the VO2max), with greater wall thickness, diastolic dimension, and oxygen uptake, in agreement with results from previous studies.20-22 Nonetheless, there were no differences in I/D polymorphism according to the cardiovascular demand (Figure 1): the most common genotype in all the sports categories was DI.

Physical exercise activates the RAAS and stimulates synthesis of various components of this system, such as ACE; hence, increases in angiotensin II concentrations have been related to myocardial growth. Nevertheless, the degree to which left ventricular mass increases in response to exercise is highly variable. It has been shown in a population-based sample that individuals homozygous for the D allele have higher plasma and tissue ACE concentrations and a higher risk of experiencing left ventricular hypertrophy (LVH) than persons with genotypes DI or II.23 This has led to the idea that athletes homozygous for the D allele with intensive training are more likely to develop LVH. In several studies, the different genotypes of ACE I/D polymorphism have been associated with the sports discipline being practiced. Some authors24-26 have found an association between genotype DD and the development of LVH in athletes practicing aerobic endurance sports. Other authors27-28 have reported an association of the I allele with aerobic sports and the D allele with power sports, and a relationship between I allele and good cardiovascular adaptation. However, Karjalainen et al5 found no association between LVH and I/D polymorphism in athletes practicing aerobic endurance sports. These disparate results may be due to ethic differences and the fact that some of these studies were performed in a small sample or only included sports having a similar cardiovascular demand. The present study included a broad sample of 32 sports disciplines with differing cardiovascular demands, and the participants were all high-level athletes. Our results are consistent with the findings of Karjalainen et al5 and those of other authors who, like us, studied a variety of sports.29 The D allele was the most common in our study (60.4%), as in the majority of non-athlete populations in Europe, Lebanon, and the United States,30-35 in individuals practicing aerobic endurance sports in Spain,9,24 and in elite athletes in Israel25 and Italy.27 This finding differs from the data recorded in an Asian population36 and in rowers in Australia,28 a fact possibly related to the different ethnic origins of these groups. The polymorphism distribution in different populations is shown in Table 5.9,24,25,27,28,30-36

TABLE 5. Distribution of Angiotensin-Converting Enzyme Gene I/D Polymorphism in Various Populations

With regard to the anthropometric profile, no differences were found between athletes grouped according to ACE gene I/D polymorphism, and the results obtained were similar to those reported in other studies involving elite athletes, who show a lower percentage of fat mass and higher percentage of muscle mass than sedentary population.13,14 Previous studies have associated the I allele with an increase in the BMI and obesity and the D allele with a lower BMI37 and greater skeletal muscle development.38,39 In the present study, only 8 male athletes had a BMI within the obese range, with no predominance of any genotype: 3 in DD (5.1%), 4 in DI (3.6%), and 1 in II (4.3%). In addition, the indicators of muscle development (muscle mass, percentage of muscle mass, and FFMI) were similar in the I/D polymorphism groups. This may be because all the individuals studied were elite athletes and therefore, their body composition was already optimal, while being determined by both genetic and environmental factors.

Because multiple factors have an impact on success in sports, it is difficult to evaluate the importance of ACE I/D polymorphism alone in this regard. Although we did not establish a control sedentary population to determine differences, comparison of the results in our series with those of sedentary Spanish controls from previous studies9,30 seems to indicate a greater prevalence of genotype DI in elite athletes. This may reflect higher aerobic capacity, but we do not have a physiologic explanation for the association between ACE I/D polymorphism and adaptation to training.

Limitations of the Study

The study sample contained almost 300 athletes, but when they were grouped according to the Mitchell classification, the number of individuals in categories IA, IIA, and IIIB was small. This is because these categories contain sports with a scant following in Spain (eg, cricket, curling) and non-olympic sports (eg, motorcycling, auto racing, diving); athletes who consult at our center are mainly those practicing olympic sports. In addition, the overall sample was not in Hardy-Weinberg equilibrium for I/D polymorphism, with an excess of DI heterozygotes (c2=9.88; degree of freedom, 1; P=.0017). It is unlikely that this was due to genotyping errors because 20% of the tests were randomly repeated and the same genotype as in the previous test was identified in all cases. Genotype DI was found in the highest percentage (56.5%) and this differentiates our series from the majority of those shown in Table 5. The percentage of this genotype is, however, similar to that found in samples of athletes practicing endurance sports in the Canary Islands24 and anaerobic sports in Italy,27 which leads us to believe that the differences may be due to sample bias: in all cases the populations were individuals practicing competition sports.

CONCLUSIONS

Athletes who practice sports having a high dynamic component show the greatest cardiovascular adaptation. I/D polymorphism of intron 16 of the ACE gene does not seem to have an influence on cardiovascular adaptation to training. Although the DI genotype was the most common in our population, with no differences between sexes, this fact is likely due to bias of the sample, which was entirely comprised of elite athletes. More studies in this line, with a larger number of athletes and different levels of sports (competitive and non-competitive) are needed. Based on our findings, LVH and skeletal muscle development seem to be independent of ACE I/D genotype in elite athletes.

ACKNOWLEDGMENTS

The authors are grateful for the support received from the staff of the Departments of Cardiology, Physiology, and Anthropometry and the Clinical Laboratory of Centro de Medicina del Deporte del Consejo Superior de Deportes.

ABBREVIATIONS
RAAS: renin-angiotensin-aldosterone system
VO2máx: maximal oxygen uptake
VO2 kg máx: relative maximal oxygen uptake


This study was made possible by a Coca Cola Grant (2007), awarded by the Spanish Heart Foundation.

Correspondence: Dra. A. Boraita Pérez.
Centro de Medicina del Deporte. Consejo Superior de Deportes.
El Greco, s/n. 28040 Madrid. Spain.
E-mail: araceli.boraita@csd.gob.es">araceli.boraita@csd.gob.es

Received September 7, 2009.
Accepted for publication February 2, 2010.

Bibliography

1. Douglas PS, O''Toole ML, Katz SE, Ginsburg GS. Left ventricular hypertrophy in athletes. Am J Cardiol. 1997;80:1384-8.
Medline
2. Higaki J, Aoki M, Morishita R, Kida I, Taniyama Y, Tomita N, et al. In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy. Arterioscler Thromb Vasc Biol. 2000;20:428-34.
Medline
3. Spirito P, Pelliccia A, Proschan MA, Granata M, Spataro A, Bellone P, et al. Morphology of the athlete''s heart assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol. 1994;74:802-6.
Medline
4. Crisan D, Carr J. Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn. 2000;2:105-15.
Medline
5. Karjalainen J, Kujala UM, Stolt A, Mäntysaari M, Viitasalo M, Kainulainen K, et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol. 1999;34:494-9.
Medline
6. Diet F, Graf C, Mahnke N, Wassmer G, Predel HG, Palma-Hohmann I, et al. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes. Eur J Clin Invest. 2001;31:836-42.
Medline
7. Nagashima J, Musha H, Takada H, Awaya T, Oba H, Mori N, et al. Influence of angiotensinconverting enzyme gene polymorphism on development of athlete''s heart. Clin Cardiol. 2000;23:621-4.
Medline
8. Fatini C, Guazzelli R, Manetti P, Battaglini B, Gensini F, Vono R, et al. RAS genes influence exercise-induced left ventricular hypertrophy: an elite athletes study. Med Sci Sports Exerc. 2000;32:1868-72.
Medline
9. Álvarez R, Terrados N, Ortolano R, Iglesias-Cubero G, Reguero JR, Batalla A, et al. Genetic variation in the renninangiotensin system and athletic performance. Eur J Appl Physiol. 2000;82:117-20.
Medline
10. Mitchell JH, Haskell W, Snell P, Van Camp SP. 36th Bethesda Conference. Task force 8. Classification of Sports. J Am Coll Cardiol. 2005;45:364-7.
11. Marfell-Jones M, Olds T, Stewart A, Carter L. International standards for anthropometric assessment. 2.a ed. Potchefstroom: The International Society for the Advancement of Kinanthropometry (ISAK);2006.
12. Whiters RT, Craig NP, Bourdon PC, Norton KI. Relative body fat and anthropometric prediction of body density of male athletes. Eur J Appl Physiol. 1987;56:191-200. Modificada en: Norton K, Olds T. Anthropometricia. University of New South Wales Press;1996.
13. Withers RT, Whittingham NO, Norton KI, Laforgia J, Ellis MW, Crockett A. Relative body fat and anthropometric prediction of body density of female athletes. Eur J Appl Physiol. 1987;56:169-80.
14. Lee RC, Wang Z, Heo M, Ross R, Janssen I, Heymsfield SB. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr. 2000;72:796-803.
Medline
15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-67.
Medline
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
Medline
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-8.
Medline
18. Rabadan M, Segovia JC. Pruebas de esfuerzo directas. En: Segovia JC, López-Silvarrey FJ, Legido JC, editores. Manual de valoración functional. Aspectos clínicos y fisiológicos. 2.a ed. Madrid: Elsevier;2008. p. 269-92.
19. Howley ET, Basset DR, Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc. 1995;27:1292-301.
Medline
20. Fagard RH. Athlete''s heart: a meta-analysis of the echocardiographic experience. Int J Sports Med. 1996;17 Suppl 3:S140-4.
21. Pellicia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiological cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295.
Medline
22. Boraita A, Serratosa L, Lamiel R, Santaella O. Ecocardiografía del deportista. En: Manonelles P, Boraita A, Luengo E, Pons C, editores. Cardiología del deporte. Barcelona: FEMEDE & Nexus;2003. p. 205-47.
23. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-8.
Medline
24. Hernández D, De la Rosa A, Barragán A, Barrios Y, Salido E, Torres A, et al. The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes. J Am Coll Cardiol. 2003;42:527-32.
Medline
25. Amir O, Amir R, Yamin Ch, Attia E, Eynon N, Sagiv Mo, et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol. 2007;92:881-6.
Medline
26. Woods D, Hickman M, Jamshidi Y, Brull D, Vassiliou V, Jones A, et al. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet. 2001;108:230-2.
Medline
27. Scanavini D, Bernardi F, Castoldi E, Conconi F, Mazzoni G. Increased frequency of the homozygous II ACE genotype in Italian Olympic endurance athletes. Eur J Hum Genet. 2002;10:576-7.
Medline
28. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS, et al. Elite endurance athletes and the ACE I allele —the role of genes in athletic performance. Hum Genet. 1998;103:48-50.
Medline
29. Taylor R, Mamotte C, Fallon K, Van Bockxmeer F. Elite athletes and the gene for angiotensin-converting enzyme. J Appl Phyisiol. 1999;87:1035-7.
30. Hernández E, Medina A, Rodríguez FJ, Hernández O, Melián F, Delgado A, et al. Relevancia de los polimorfismos génicos del sistema renina-angiotensina en la enfermedad coronaria. Rev Esp Cardiol. 2002;55:92-9.
Medline
31. Danser AH, Schalekanp MA, Bax WA, Van den Brink AM, Saxena PR, Riegger GA, et al. Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit Care Med. 2002;30:2236-41.
Medline
32. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, et al. Contribution of genetic polimorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) Study Group. J Clin Invest. 1997;99:1585-95.
Medline
33. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, et al. No association of converting enzyme insetion/deletion polymorphism with inmmunoglobulin A glomerulo-nephritis. Am J Kidney Dis. 1995;26:727-31.
Medline
34. Sabbagh AS, Otrock ZK, Mahfoud ZR, Zaatari GS, Mahfouz RA. Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature. Mol Biol Rep. 2007;34:47-52.
Medline
35. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-11.
Medline
36. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin dependent diabetes mellitus. Nephron. 1995;70:455-9.
Medline
37. Wacker MJ, Godard MP, McCabe EH, Donnelly JE, Kelly JK. Sex difference in the association of the angiotensin converting enzyme I/D polymorphism and body mass index. Med Sci Omint. 2008;14:CR353-7.
38. Folland J, Leach B, Little T, Hawker K, Myerson S, Montgomery H, et al. Angiotensin-conerting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol. 2000;85:575-9.
Medline
39. Charbonneau DE, Hanson ED, Ludlow AT, Delmonico MJ, Hurley BF, Roth SM. ACE genotype and the muscle hypertrophic and strength responses to strength training. Med Sci Sports Exerc. 2007;40:677-8.
Medline

1885-5857/© 2010 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved

Cookies
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.
Cookies policy
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.